Then, we specifically examined gene expression in the TME, using RNA isolated from baseline tumor tissue samples which were obtained from ICC patients who received programmed cell death-1 (PD-1) inhibitor combined with GemCis as first-line therapy. This evidence concerns the gene PDCD1 and neoplasm.